auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Purpose
CIIP Korea project NextGenADC will integrate the protein engineering expertise and enhanced antibody delivery technology of iProgen Biotech Inc. (Canada) with the unique linker-payload and site-specific conjugation technologies of AbTis Co., Ltd. (Korea). Together, this international partnership aims to create a next generation antibody-drug conjugate (ADC) as a potential therapeutic agent with a superior efficacy and safety profile for treating patients with solid tumours.
iProgen Biotech Inc. × Unknown
3 grants totalling $1.2M
Canadian International Innovation Program
117 grants totalling $47.6M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| H2M | $600.0K | Canadian International Innovation Progra... |
| H2M | $600.0K | Canadian International Innovation Progra... |
| GN Corp Inc | $600.0K | Canadian International Innovation Progra... |
| Verto; Verto Health | $600.0K | Canadian International Innovation Progra... |
| iProgen Biotech Inc. | $600.0K | Canadian International Innovation Progra... |